Ozmosi | Piroctone Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Piroctone

Alternative Names: piroctone
Clinical Status: Inactive
Latest Update: 2026-03-04
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action:

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical, Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Chile | Colombia | India | New Zealand | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Cosmetique Active International
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT07133334

 VCY 24-011

N/A

Completed

Dandruff

2025-08-18

2026-03-05

NCT05630027

 AC5+

N/A

Completed

Alopecia

2020-06-30

2022-11-30

Primary Endpoints

Recent News Events

Date

Type

Title

01/27/2026

News Article

 KilgourMD Introduces a New Standard in Prestige Haircare with Biotech-Driven Shampoo and Conditioner

11/21/2025

News Article

 Pantene Introduces the All-New Abundant & Strong Collection to Reduce Hair Shedding and Grow Healthier, More Abundant Hair

03/27/2024

PubMed

 Evaluation of novel cosmetic shampoo formulations against Malassezia species: Preliminary results of anti-dandruff shampoo formulations.

03/15/2024

PubMed

 Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars.

01/09/2024

PubMed

 Scalp microbiome composition changes and pathway evaluations due to effective treatment with Piroctone Olamine shampoo.

10/12/2023

News Article

 Anti-dandruff Agent Additive Market Size is Expected to Exhibit highest Growth by 2029

09/07/2023

News Article

 The PVB Film market's types, applications, and regional analysis are all thoroughly covered in this report, with a projected CAGR of 7.9% for the 2023 - 2030 period.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions